NCT00095940 - Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Recurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Brain Stem GliomaRecurrent Childhood EpendymomaRecurrent Childhood Giant Cell GlioblastomaRecurrent Childhood GlioblastomaRecurrent Childhood GliosarcomaRecurrent Childhood MedulloblastomaRecurrent Childhood Oligodendroglioma

Interventions

DRUG

lapatinib ditosylate

Given orally

PROCEDURE

therapeutic conventional surgery

Undergo surgery

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

PROCEDURE

positron emission tomography

Correlative studies

PROCEDURE

magnetic resonance imaging

Correlative studies

Trial Locations (1)

38105

Pediatric Brain Tumor Consortium, Memphis

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH